Somatic BRCA2 Mutation-Positive Concurrent Accessory Male Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC): Excellent Efficacy of Palbociclib, Fulvestrant and Leuprolide in Platinum-Exposed and Endocrine-Refractory BC Associated with Cyclin D1 and FGFR1 Amplification and of Carboplatin, Paclitaxel and Radiation in NSCLC

Accessory male breast cancer (BC) is a rare entity and is associated with poor outcome. We report a 76-year-old patient who was diagnosed with concurrent accessory breast and primary lung cancer, both were positive for somatic BRCA-2 (E1593D) mutation. He received concurrent radiation and platinum-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yu, Li, Ningjing, Eapen, Ann, Parajuli, Ritesh, Mehta, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616081/
https://www.ncbi.nlm.nih.gov/pubmed/31320873
http://dx.doi.org/10.1159/000501304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616081/
https://www.ncbi.nlm.nih.gov/pubmed/31320873
http://dx.doi.org/10.1159/000501304

Ejemplares similares